← Back to Clinical Trials
Recruiting NCT07220798

NCT07220798 Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07220798
Status Recruiting
Phase
Sponsor Visiting Nurse Service of New York
Condition Heart Failure
Study Type INTERVENTIONAL
Enrollment 316 participants
Start Date 2026-05-28
Primary Completion 2030-04-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 101 Years
Study Type INTERVENTIONAL
Interventions
ViCCY

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 316 participants in total. It began in 2026-05-28 with a primary completion date of 2030-04-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator group, stratifying randomization by caregiver sex (male/female), relationship (spouse/partner or child), and race (white/other)- factors known to influence caregiving burden, perceived stress, and receptivity to the intervention. We will encourage caregivers to use their own devices but provide tablet devices with wireless network access if needed. The intervention group will receive 10 sessions of ViCCY over 6 months.

Eligibility Criteria

Inclusion Criteria: * Patient Inclusion Criteria 1. Older adults (=\>50 years of age) 2. Enrolled in Home Health Care 3. Documented to have HF 4. Mild to moderate CI on the BIMS or OASIS items 5. Able to provide informed consent 6. Able to provide self-report data * Caregiver Inclusion Criteria 1. Adults (=\>18 years of age) 2. Spouse/partner/child or other informal caregiver living with or in close proximity to the patient 3. Caregiver of a home care patient who is currently receiving or recently received services and who has mild to severe cognitive impairment 4. Reporting poor self-care on screening (Health Self-Care Neglect scale score =\>2) 5. Reporting poor mental health on screening (screened with the PROMIS Global Mental Health 4a score \<12) 6. Caregiving or supporting the patient at least 8 hours/week 7. Able to complete the protocol, e.g., adequate vision and hearing, English speaking. 8. Able to provide informed consent 9. Able to use technology Exclusion Criteria: * Patient Exclusion Criteria 1. Dementia (ICD-10 code for dementia) 2. Enrolled in hospice 3. Non-English speaking * Caregiver Exclusion Criteria 1. Non-English speaking

Contact & Investigator

Central Contact

Barbara Riegel, PhD, RN

✉ briegel@nursing.upenn.edu

📞 215.898.9927

Principal Investigator

Barbara Riegel, PhD, RN

PRINCIPAL INVESTIGATOR

VNS Health (formerly Visiting Nurse Service of New York)

Frequently Asked Questions

Who can join the NCT07220798 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 101 Years, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07220798 currently recruiting?

Yes, NCT07220798 is actively recruiting participants. Contact the research team at briegel@nursing.upenn.edu for enrollment information.

Where is the NCT07220798 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT07220798 clinical trial?

NCT07220798 is sponsored by Visiting Nurse Service of New York. The principal investigator is Barbara Riegel, PhD, RN at VNS Health (formerly Visiting Nurse Service of New York). The trial plans to enroll 316 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology